These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28054767)

  • 1. Orthogonal Genetic Regulation in Human Cells Using Chemically Induced CRISPR/Cas9 Activators.
    Bao Z; Jain S; Jaroenpuntaruk V; Zhao H
    ACS Synth Biol; 2017 Apr; 6(4):686-693. PubMed ID: 28054767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances of CRISPR/Cas9 activation system].
    Ding X; Pan Z; Yang L; Luo X; Jiang N; Zhu M; Wu C; Lan G; Li P
    Sheng Wu Gong Cheng Xue Bao; 2022 Aug; 38(8):2713-2724. PubMed ID: 36002405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of an Inducible CRISPR/Cas9 System for CXCR4 Gene and Demonstration of its Effects on MKN-45 Cells.
    Peng Y; Yang T; Tang X; Chen F; Wang S
    Cell Biochem Biophys; 2020 Mar; 78(1):23-30. PubMed ID: 31875277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplexed sgRNA Expression Allows Versatile Single Nonrepetitive DNA Labeling and Endogenous Gene Regulation.
    Shao S; Chang L; Sun Y; Hou Y; Fan X; Sun Y
    ACS Synth Biol; 2018 Jan; 7(1):176-186. PubMed ID: 28849913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming of Fibroblasts to Human iPSCs by CRISPR Activators.
    Weltner J; Trokovic R
    Methods Mol Biol; 2021; 2239():175-198. PubMed ID: 33226620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical Control of a CRISPR-Cas9 Acetyltransferase.
    Shrimp JH; Grose C; Widmeyer SRT; Thorpe AL; Jadhav A; Meier JL
    ACS Chem Biol; 2018 Feb; 13(2):455-460. PubMed ID: 29309117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Building Endogenous Gene Connections through RNA Self-Assembly Controlled CRISPR/Cas9 Function.
    Lin J; Wang WJ; Wang Y; Liu Y; Xu L
    J Am Chem Soc; 2021 Dec; 143(47):19834-19843. PubMed ID: 34788038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulating CRISPR/Cas9 Function through Conditional Guide RNA Control.
    Brown W; Zhou W; Deiters A
    Chembiochem; 2021 Jan; 22(1):63-72. PubMed ID: 32833316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity.
    Basila M; Kelley ML; Smith AVB
    PLoS One; 2017; 12(11):e0188593. PubMed ID: 29176845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guide RNAs: A Glimpse at the Sequences that Drive CRISPR-Cas Systems.
    Briner AE; Barrangou R
    Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Evaluation of CRISPRa and CRISPRi Modalities Enables Development of a Multiplexed, Orthogonal Gene Activation and Repression System.
    Martella A; Firth M; Taylor BJM; Göppert A; Cuomo EM; Roth RG; Dickson AJ; Fisher DI
    ACS Synth Biol; 2019 Sep; 8(9):1998-2006. PubMed ID: 31398008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing on-target cleavage efficiency for CRISPR/Cas9-induced large fragment deletion in Myxococcus xanthus.
    Yang YJ; Wang Y; Li ZF; Gong Y; Zhang P; Hu WC; Sheng DH; Li YZ
    Microb Cell Fact; 2017 Aug; 16(1):142. PubMed ID: 28814300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas9-based photoactivatable transcription system.
    Nihongaki Y; Yamamoto S; Kawano F; Suzuki H; Sato M
    Chem Biol; 2015 Feb; 22(2):169-74. PubMed ID: 25619936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional Regulation with CRISPR/Cas9 Effectors in Mammalian Cells.
    Pham H; Kearns NA; Maehr R
    Methods Mol Biol; 2016; 1358():43-57. PubMed ID: 26463376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas9 system-driven site-specific selection pressure on Herpes simplex virus genomes.
    Li Z; Bi Y; Xiao H; Sun L; Ren Y; Li Y; Chen C; Cun W
    Virus Res; 2018 Jan; 244():286-295. PubMed ID: 28279800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent activation of gene expression is achieved using CRISPR and small molecules that recruit endogenous chromatin machinery.
    Chiarella AM; Butler KV; Gryder BE; Lu D; Wang TA; Yu X; Pomella S; Khan J; Jin J; Hathaway NA
    Nat Biotechnol; 2020 Jan; 38(1):50-55. PubMed ID: 31712774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational guide RNA engineering for small-molecule control of CRISPR/Cas9 and gene editing.
    Liu X; Xiong W; Qi Q; Zhang Y; Ji H; Cui S; An J; Sun X; Yin H; Tian T; Zhou X
    Nucleic Acids Res; 2022 May; 50(8):4769-4783. PubMed ID: 35446403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iKA-CRISPR hESCs for inducible and multiplex orthogonal gene knockout and activation.
    Ma S; Lv J; Sun J; Tang P; Li H; Zhou H; Zhang Z; Lin Y; Rong Z
    FEBS Lett; 2018 Jul; 592(13):2238-2247. PubMed ID: 29869798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells.
    Steyer B; Carlson-Stevermer J; Angenent-Mari N; Khalil A; Harkness T; Saha K
    Acta Biomater; 2016 Apr; 34():143-158. PubMed ID: 26747759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transfer.
    Mahendra C; Christie KA; Osuna BA; Pinilla-Redondo R; Kleinstiver BP; Bondy-Denomy J
    Nat Microbiol; 2020 Apr; 5(4):620-629. PubMed ID: 32218510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.